A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial
- DOI
- 10.1371/journal.pone.0291285
- Published
- 2024-07-11
- Container
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pone.0291285,
title = {A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial},
author = {Venkataramanan Srinivasan and Victoria Homer and Darren Barton and Abigail Clutterbuck-James and Siân Jenkins and Claire Potter and Kristian Brock and Ann Logan and Donna Smith and Lars Bruce and Zsuzsanna Nagy and Simon P. Bach},
year = {2024},
journal = {PLOS ONE},
doi = {10.1371/journal.pone.0291285},
url = {https://doi.org/10.1371/journal.pone.0291285}
}RIS
TY - JOUR TI - A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial AU - Venkataramanan Srinivasan AU - Victoria Homer AU - Darren Barton AU - Abigail Clutterbuck-James AU - Siân Jenkins AU - Claire Potter AU - Kristian Brock AU - Ann Logan AU - Donna Smith AU - Lars Bruce AU - Zsuzsanna Nagy AU - Simon P. Bach PY - 2024 JO - PLOS ONE DO - 10.1371/journal.pone.0291285 UR - https://doi.org/10.1371/journal.pone.0291285 ER -
APA
Srinivasan, V., Homer, V., Barton, D., Clutterbuck-James, A., Jenkins, S., Potter, C., Brock, K., Logan, A., Smith, D., Bruce, L., Nagy, Z., & Bach, S. P. (2024). A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0291285
Source records
- crossref · retrieved 2026-09-26T10:35:51.894Z